Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

58.36 USD +0.66 (+1.14%)
Official Closing Price Updated: 7:00 PM EDT, Oct 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Bristol-Myers Squibb

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Week In Review: Hansoh Signs $456 Million Deal For siRNA Products
Hansoh Pharma of Shanghai announced a $456 million agreement to develop siRNA products in Greater China from South Korea's OliX Pharma. Hansoh will make an upfront payment of $6.5 million and up to... 
Tags Healthcare Pharma/Biotech Market News
From TalkMarkets
Week in Review: Hansoh Signs $456 Million Deal for siRNA Products
Deals and Financings   Hansoh Pharma of  Shanghai  announced a $456 million agreement to develop siRNA products from  South Korea 's OliX Pharma in Greater China; Abbisko, a  Shanghai  biopharma,... 
From ChinaBio® Today
Week in Review: Hansoh Signs $456 Million Deal for siRNA Products
Deals and Financings   Hansoh Pharma of  Shanghai  announced a $456 million agreement to develop siRNA products from  South Korea 's OliX Pharma in Greater China; Abbisko, a  Shanghai  biopharma,... 
From ChinaBio® Today
Europe's Unicorns
After markets jumped yesterday, we saw a lot of bounce today although gold fell back a bit. 
Tags Stocks / Equities Market News
From TalkMarkets
3 Highly Profitable Stocks Wall Street Thinks Will Soar 39% or More
There are good reasons behind analysts' optimism about these stocks. 
Tags BIIB VRTX CRSP
From Motley Fool
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
You can perch on a 1-legged stool and balance precariously on 2, but if you want to settle in with comfort and safety, you need 3 sturdy ... 
Tags General NVS JNJ
From Benzinga
BeiGene and Bristol-Myers in Fight over China Abraxane Distribution Deal
The $1.4 billion landmark deal between Beijing 's BeiGene and Celgene (now Bristol-Myers) is falling apart. The companies are arguing over BeiGene's China distribution rights for Abraxane, a... 
From ChinaBio® Today
DGRW, MO, TXN, BMY: Large Inflows Detected at ETF
Symbols mentioned in this story: DGRW, MO, TXN, BMY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Death Cross Looms Over Bristol-Myers Squibb Investors
If history is any guide, there may be trouble ahead for shares of Bristol-Myers Squibb(NYSE:BMY). A so-called "death cross" has formed ... 
Tags Movers Benzinga Markets
From Benzinga
MINDCURE's "Desire Project" uses MDMA to Treat Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
Photo by Visual Stories || Micheile on Unsplash Mental health is becoming a major concern globally in the wake of the Covid-19 ... 
Tags Benzinga MRK Partner Content
From Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags HOOK KMDA TFFP
From Benzinga
3 Top Warren Buffett Stocks to Buy in October
Two of the three haven't been big winners for Buffett so far this year. But that could soon change. 
Tags RH BRK/B BRK/A
From Motley Fool
Noteworthy Friday Option Activity: BMY, LH, RCL
Among the underlying components of the S&P 500 index, we saw noteworthy options trading volume today in Bristol Myers Squibb Co. (BMY), where a total of 72,939 contracts have traded so far,... 
Tags Stocks
From Market News Video
Evotec Expands Neuroscience Collaboration with Bristol Myers
Bristol Myers Squibb & Co(NYSE: BMY) hasexpanded its neuroscience collaborationwithEvotec SE(OTC: ... 
Tags Biotech General EVTCY
From Benzinga
5 Warren Buffett Stocks to Buy Hand Over Fist for the Fourth Quarter
Riding the Oracle of Omaha's coattails has long been a moneymaking strategy. 
Tags Market News BMY MA
From Motley Fool
Is an Acquisition of Acceleron a Smart Move for Merck?
Merck will pick up a promising pipeline candidate with the deal. 
Tags MRK Market News XLRN
From Motley Fool
Markets Boosted
Good news helped stock prices. 
Tags Stocks / Equities Market News
From TalkMarkets
Bristol Myers' TYK2 Inhibitor Disappoints In Mid-Stage Ulcerative Colitis Study
Bristol Myers Squibb & Co(NYSE: BMY) hasannounced topline datafrom the Phase 2 LATTICE-UC study evaluating ... 
Tags ulcerative colitis General Briefs
From Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BDTX ADVM TPTX
From Benzinga
Best Pharmaceutical Stocks To Buy In 2021
The global pharmaceutical market has experienced significant growth in recent years. As of end-2020, the total global pharmaceutical market was valued at about 1.27 trillion U.S. dollars. 
Tags Market News Stocks / Equities Pharma/Biotech
From TalkMarkets
Cannabis Movers & Shakers: TOCC, 1933 Industries, Iter Investments, Greenlane
Former TilrayExec Steven Yoo Named Texas Original Compassionate Cultivation's New CFO Texasmedical cannabis ... 
Tags BMY Market News Cannabis
From Benzinga
3 Value Stocks That'll Make You Richer in the Fourth Quarter (and Beyond)
Big-time bargains are available for opportunistic long-term investors. 
Tags AGNC WBA Market News
From Motley Fool
Analysts Anticipate USMV To Hit $83
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
This Healthcare Company Is Using AI to Develop Drugs
Could this technology be the future of the pharmaceutical industry? 
Tags SNY GILD SDGR
From Motley Fool
2 Ridiculously Cheap Growth Stocks to Buy
Though these companies have recorded solid financials of late, investors are overlooking them. 
Tags BMY Market News NFLX
From Motley Fool
Bristol Myers Squibb: Should You Buy the Dip?
Short-term volatility can be a patient, long-term investor's best friend. 
Tags PFE ^GSPC Market News
From Motley Fool
Noteworthy ETF Outflows: XLV, ABBV, LLY, BMY
Symbols mentioned in this story: XLV, ABBV, LLY, BMY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ... 
Tags CYTK PLRX Biotech
From Benzinga
These 3 Dividend Stocks Could Soar Between 23% and 32%, According to Wall Street
Solid dividends plus strong growth? You get both with these stocks. 
Tags MA BMY Market News
From Motley Fool
BMY November 12th Options Begin Trading
Investors in Bristol Myers Squibb Co. (BMY) saw new options begin trading today, for the November 12th expiration.. 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.